Dr. Juergen Hahn | Source | department head of the Department of Biomedical Engineering at Rensselaer Pol...
Dr. Juergen Hahn
Juergen Hahn is the department head of the Department of Biomedical Engineering at Rensselaer Polytechnic Institute in addition to holding an appointment in the Department of Chemical & Biological Engineering. He received his Diploma degree in engineering from RWTH Aachen, Germany, in 1997, and his MS and Ph.D. degrees in chemical engineering from the University of Texas, Austin, in 1998 and 2002, respectively. He was a post-doctoral researcher at the Chair for Process Systems Engineering at RWTH Aachen, Germany, before joining the Department of Chemical Engineering at Texas A&M University, College Station, in 2003 and moving to the Rensselaer Polytechnic Institute in 2012. His research interests include systems biology and process modeling and analysis with over 140 peer-reviewed publications in print. Dr. Hahn is a recipient of a Fulbright scholarship (1995/96), received the Best Referee Award for 2004 from the Journal of Process Control, the CPC 7 Outstanding Contributed Paper Award in 2006, was named Outstanding Reviewer by the journal Automatica in 2005, 2006, 2007, and 2010 CAST Outstanding Young Researcher, and has been elected as an AIMBE Fellow in 2013, an AIChE Fellow in 2020, and a Fellow of BMES in 2022. He served on the IEEE CSS Board of Governors in 2016 and has been a CACHE Trustee since 2014. He is currently serving as deputy editor-in-chief for the Journal of Process Control, as editor for the journal Optimal Control: Applications and Methods, and as associate editor for the journals Control Engineering Practice, the Journal of Advanced Manufacturing and Processing, and the Journal of Personalized Medicine.
-
Rensselaer Polytechnic Institute
department head of the Department of Biomedical Engineering
-
Three Autism Subgroups With Distinct Prenatal Risk Factors - Neuroscience News
Using large data sets, researchers determined children on the autism spectrum can be broken into three subgroups based upon co-occurring conditions, and those subgroups are associated with different prenatal risk factors. Infections, anti-inflammatory and other complex medications were associated with one group, while join disorders and immune system problems were associated with another. The third subgroup was associated with overall pregnancy complications. Researchers have developed a new blood test that can for autism and prenatal risk factors for ASD.
Article
-
Autism has always been diagnosed as one condition. Through our research, we sought to determine differences within the condition.
Now this work not only shows that there are subgroups of children with different co-occurring conditions, but that there are different prenatal risk factors associated with these subgroups. Given the significant differences we are seeing for risk factors, this raises the questions to what degree other aspects of ASD research would be affected by this type of subgrouping.
Ultimately, diagnosis and interventions may also be influenced by the presentation of ASD and just using one medical diagnostic category for ASD may not be sufficient in the future.
